Investing.com - Merck&Co (NYSE:MRK) reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck&Co announced earnings per share of $1.74 on revenue of $12.55B. Analysts polled by Investing.com anticipated EPS of $1.44 on revenue of $12.19B.
Merck&Co shares are down 13% from the beginning of the year and are trading at $78.84 , down-from-52-week-high.They are under-performing the Dow Jones which is down 2.99% from the start of the year.
Merck&Co follows other major Healthcare sector earnings this month
Merck&Co's report follows an earnings beat by J&J on Tuesday, October 13, 2020, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar